In theory I agree, however emphirically the cash inflow has only increased through accummulation of small contracts ie <$1M. The increase in job adverts imply a far reaching network though I don't think we are going to see a substantial increase in revenue or share price until we start landing those large POC's. If it's just one POC that won't help much as it will cause a spike and retrace - the challenege is to sustain revenue by securing subsequent POC's, then we know the business is maturing.
- Forums
- ASX - By Stock
- AR9
- Ann: Quarterly Results Investor Update Webinar
Ann: Quarterly Results Investor Update Webinar, page-65
-
- There are more pages in this discussion • 134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AR9 (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.9¢ |
Change
0.001(1.47%) |
Mkt cap ! $19.49M |
Open | High | Low | Value | Volume |
6.9¢ | 6.9¢ | 6.9¢ | $1.959K | 28.38K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 176612 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 37943 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 176612 | 0.069 |
3 | 320506 | 0.068 |
2 | 104477 | 0.067 |
4 | 220538 | 0.066 |
1 | 7698 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 37943 | 3 |
0.073 | 19442 | 1 |
0.074 | 66155 | 1 |
0.075 | 10000 | 1 |
0.077 | 180000 | 1 |
Last trade - 11.53am 13/11/2024 (20 minute delay) ? |
Featured News
AR9 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online